Still Time to Catch Big Growth in Biotech: George Zavoico

August 16, 2013 Biotech has had a scorching run for more than a year and a half, but as broader markets approach more realistic valuations with less potential upside, it becomes even more important to be invested in the right companies with truly meaningful catalysts on the horizon.

http://www.investorideas.com/news/2013/biotech/08162.asp